tetano
Editor, Senior Moderator
Am J Public Health
. 2022 Sep 15;e1-e5.
doi: 10.2105/AJPH.2022.306971. Online ahead of print.
In-Home COVID-19 Testing for Children with Medical Complexity: Feasibility and Association With School Attendance and Safety Perceptions
Ryan J Coller[SUP] 1 [/SUP], Michelle M Kelly[SUP] 1 [/SUP], Kristina Devi Howell[SUP] 1 [/SUP], Gemma Warner[SUP] 1 [/SUP], Sabrina M Butteris[SUP] 1 [/SUP], Mary L Ehlenbach[SUP] 1 [/SUP], Nicole Werner[SUP] 1 [/SUP], Barbara Katz[SUP] 1 [/SUP], Joseph A McBride[SUP] 1 [/SUP], Madeline Kieren[SUP] 1 [/SUP], Shawn Koval[SUP] 1 [/SUP], Gregory P DeMuri[SUP] 1 [/SUP]
Affiliations
Abstract
The REstarting Safe Education and Testing program for children with medical complexity was implemented in May 2021 at the University of Wisconsin to evaluate the feasibility of in-home rapid antigen severe acute respiratory syndrome coronavirus 2 testing among neurocognitively affected children. Parents or guardians administered BinaxNOW rapid antigen self-tests twice weekly for three months and changed to symptom and exposure testing or continued surveillance. In-home testing was feasible: nearly all (92.5%) expected tests were conducted. Symptomatic testing identified seven of nine COVID-19 cases. School safety perceptions were higher among those opting for symptom testing. Clinical Trials.gov identifier: NCT04895085. (Am J Public Health. Published online ahead of print September 15, 2022:e1-e5. https://doi.org/10.2105/AJPH.2022.306971).
. 2022 Sep 15;e1-e5.
doi: 10.2105/AJPH.2022.306971. Online ahead of print.
In-Home COVID-19 Testing for Children with Medical Complexity: Feasibility and Association With School Attendance and Safety Perceptions
Ryan J Coller[SUP] 1 [/SUP], Michelle M Kelly[SUP] 1 [/SUP], Kristina Devi Howell[SUP] 1 [/SUP], Gemma Warner[SUP] 1 [/SUP], Sabrina M Butteris[SUP] 1 [/SUP], Mary L Ehlenbach[SUP] 1 [/SUP], Nicole Werner[SUP] 1 [/SUP], Barbara Katz[SUP] 1 [/SUP], Joseph A McBride[SUP] 1 [/SUP], Madeline Kieren[SUP] 1 [/SUP], Shawn Koval[SUP] 1 [/SUP], Gregory P DeMuri[SUP] 1 [/SUP]
Affiliations
- PMID: 36108256
- DOI: 10.2105/AJPH.2022.306971
Abstract
The REstarting Safe Education and Testing program for children with medical complexity was implemented in May 2021 at the University of Wisconsin to evaluate the feasibility of in-home rapid antigen severe acute respiratory syndrome coronavirus 2 testing among neurocognitively affected children. Parents or guardians administered BinaxNOW rapid antigen self-tests twice weekly for three months and changed to symptom and exposure testing or continued surveillance. In-home testing was feasible: nearly all (92.5%) expected tests were conducted. Symptomatic testing identified seven of nine COVID-19 cases. School safety perceptions were higher among those opting for symptom testing. Clinical Trials.gov identifier: NCT04895085. (Am J Public Health. Published online ahead of print September 15, 2022:e1-e5. https://doi.org/10.2105/AJPH.2022.306971).